Results

Total Results: 1,939 records

Showing results for "event".

181. Treatment for Acute Pain: An Evidence Map | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/acute-pain-treatment/technical-brief
     October 22, 2019 - Pain during the week or month following the inciting event and persistent opioid use were rarely reported

182. Treatment for Restless Legs Syndrome | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/restless-legs/research
     November 27, 2012 - Dopamine agonists resulted in more patients who experienced at least one adverse event (high-strength

183. Cannabis-App-F1-F4-Tables-Surveillance-Report-2 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-app-f1-f4-tables-surveillance-report-2.xlsx
     January 22, 2022 - Adverse Event Intervention B, N of Any Adverse Event (Numerator) Intervention B, N Analyzed for Any … Event (Numerator) Intervention A, N Analyzed for Serious Adverse Event (Denominator) Intervention A, … % With Serious Adverse Event Intervention B, N of Serious Adverse Event (Numerator) Intervention B, … to Adverse Event (Denominator) Intervention A, % With Withdrawals Due to Adverse Event Intervention B … Adverse Event (Denominator) Intervention B, % With Withdrawals Due to Adverse Event Intervention A,

184. Pbt-Lsr-Draft-Ets-Rcts (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/pbt-lsr-draft-ets-rcts.xlsx
     March 15, 2022 - Adverse Event Intervention B, N of Any Adverse Event (Numerator) Intervention B, N Analyzed for Any … Event (Numerator) Intervention A, N Analyzed for Serious Adverse Event (Denominator) Intervention A, … % With Serious Adverse Event Intervention B, N of Serious Adverse Event (Numerator) Intervention B, … to Adverse Event (Denominator) Intervention A, % With Withdrawals Due to Adverse Event Intervention B … Adverse Event (Denominator) Intervention B, % With Withdrawals Due to Adverse Event Intervention A,

185. Cannabis-App-F1-F4-Tables-Surveillance-Report-2 0 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-app-f1-f4-tables-surveillance-report-2_0.xlsx
     February 16, 2022 - Adverse Event Intervention B, N of Any Adverse Event (Numerator) Intervention B, N Analyzed for Any … Event (Numerator) Intervention A, N Analyzed for Serious Adverse Event (Denominator) Intervention A, … % With Serious Adverse Event Intervention B, N of Serious Adverse Event (Numerator) Intervention B, … to Adverse Event (Denominator) Intervention A, % With Withdrawals Due to Adverse Event Intervention B … Adverse Event (Denominator) Intervention B, % With Withdrawals Due to Adverse Event Intervention A,

186. Cannabis-2022-Update-Surv-Rep-1-App-F1-4 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-update-surv-rep-1-app-F1-4.xlsx
     January 01, 2022 - Adverse Event Intervention B, N of Any Adverse Event (Numerator) Intervention B, N Analyzed for Any … Event (Numerator) Intervention A, N Analyzed for Serious Adverse Event (Denominator) Intervention A, … % With Serious Adverse Event Intervention B, N of Serious Adverse Event (Numerator) Intervention B, … to Adverse Event (Denominator) Intervention A, % With Withdrawals Due to Adverse Event Intervention B … Adverse Event (Denominator) Intervention B, % With Withdrawals Due to Adverse Event Intervention A,

187. Cer-250-Cannabis-Tables-E1-E4-2022-Update 0 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-tables-e1-e4-2022-update_0.xlsx
     January 01, 2022 - Adverse Event Intervention B, N of Any Adverse Event (Numerator) Intervention B, N Analyzed for Any … Event (Numerator) Intervention A, N Analyzed for Serious Adverse Event (Denominator) Intervention A, … % With Serious Adverse Event Intervention B, N of Serious Adverse Event (Numerator) Intervention B, … to Adverse Event (Denominator) Intervention A, % With Withdrawals Due to Adverse Event Intervention B … Adverse Event (Denominator) Intervention B, % With Withdrawals Due to Adverse Event Intervention A,

188. Cannabis-App-F1-F4-Tables-Surveillance-Report-2 0 0 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-app-f1-f4-tables-surveillance-report-2_0_0.xlsx
     February 16, 2022 - Adverse Event Intervention B, N of Any Adverse Event (Numerator) Intervention B, N Analyzed for Any … Event (Numerator) Intervention A, N Analyzed for Serious Adverse Event (Denominator) Intervention A, … % With Serious Adverse Event Intervention B, N of Serious Adverse Event (Numerator) Intervention B, … to Adverse Event (Denominator) Intervention A, % With Withdrawals Due to Adverse Event Intervention B … Adverse Event (Denominator) Intervention B, % With Withdrawals Due to Adverse Event Intervention A,

189. Quantitative Synthesis: Learning Objectives and Recommendations (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/ehc-presentation-quantitative-synthesis-learning-objectives-recommendations.pdf
     July 01, 2019 - ► Risk difference is not the preferred measure when the event is rare. … Risk ratio is not the preferred measure if switching between occurrence and non-occurrence of the event … Low-event-rate meta-analyses of clinical trials: implementing good practices.

190. End user license.PDF (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/end-user-license.pdf
     December 02, 2009 - IN NO EVENT SHALL THE COPYRIGHT OWNER BE LIABLE FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, EXEMPLARY

191. Protocol for Quantitative Assessment of Benefit and Harm analysis of Aspirin for primary prevention (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-balancing-harms-benefits_research.pdf
     February 01, 2014 - person-time) rather than cumulative incidence (i.e., the cumulative number of participants with an event … Since we did not have access to individual time-to-event patient data, we approximated incidence rate … ischemic stroke, hemorrhagic stroke, and GI bleeds from the above meta-analysis9 to the population event … Calculating the number needed to treat for trials where the outcome is time to an event. … Source of incidence rates (per 1,000 person-years) without aspirin based on control event rates in the

192. For the elderly taking cardiovasculare medications, what are the comparative risks and benefits of commonly used herbal supplements. | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/get-involved/nominated-topics/for-the-elderly-taking-cardiovasculare-medications-what-are-the-comparative-risks-and-benefits-of-commonly-used-herbal-supplements
     April 01, 2009 - herbal supplements decrease the effectiveness of cardiovascular medications or increase the adverse event

193. Symposium on Methods for Developing and Analyzing Clinically Rich Data for Patient-Centered Outcomes Research - Part III | Effective Health Care Program
     effectivehealthcare.ahrq.gov/products/patient-outcomes-symposium/executive
     May 03, 2012 - Sedrakyan Prior Event Rate Ratio Adjustment: Numerical Studies of a Statistical Method to Address Unrecognized

194. Recurrent Nephrolithiasis in Adults: Comparative Effectiveness of Preventive Medical Strategies | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/kidney-stone-prevention/research
     July 26, 2012 - Adverse event reporting was poor.

195. Disposition of Comments for Venous Thromboembolism Prophylaxis in Orthopedic Surgery (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/blood-clots-hip-knee-surgery_disposition-comments.pdf
     March 01, 2012 - The report of a zero event rate is valuable information related to the baseline risk of events. … One method may be to utilize the control event rate in an equation and calculate NNT and NNH from the … Calculating a NNT or NNH using the pooled absolute risk difference assumes a fixed control event rate … Median time to event: DVT alone – 70 days; PE alone – 46 days; DVT and PE – 31 days. … When it results in reduced thrombotic event rates? When it is associated with less bleeding?

196. Blueprint for a Distributed Research Network To Conduct Population Studies and Safety Surveillance | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/distributed-network-blueprint/research
     June 23, 2010 - Active medical product adverse event signal detection and signal strengthening. … Evaluation of biomarkers for adverse event risk. … Potential additional issues include anti-trust policies and intellectual property concerns in the event … Potential population-based electronic data sources for rapid pandemic influenza vaccine adverse event

197. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_executive.pdf
     October 01, 2006 - Possibly there were no differences in mortality and cardiovascular event rates, although studies generally … few patients and were of too short a duration to make definitive assessments regarding these clinical event … In the angioplasty trial, no differences were found in event rates for congestive heart failure, stroke … In the surgery trial, near-identical rates of a combined outcome of atherosclerotic cardiovascular event … No direct comparisons were made of differences in adverse event rates between 4 5

198. Epoetin and Darbepoetin for Managing Anemia in Patients Undergoing Cancer Treatment: Comparative Effectiveness Update | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/cancer-anemia-update/research
     April 25, 2013 - Thromboembolic event rates were higher in ESA-treated patients (pooled RR, 1.51; 95% CI, 1.30 to 1.74

199. Pbt-Lsr-Draft-Report (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/pbt-lsr-draft-report.pdf
     February 04, 2022 - ; SOE = strength of evidence; THC = tetrahydrocannabinol; WAE = withdrawal due to adverse event. … Pooled analysis of two RCTs reporting any adverse event (1 nabilone, 1 dronabinol) found a small, non … ; SOE = strength of evidence; THC = tetrahydrocannabinol; WAE = withdrawal due to adverse event. … , or if a single patient could contribute to an event more than once. … Understanding how cannabis products’ adverse event profiles compare with other available treatments

200. Osteoporosis-Bone-Fracture Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoporosis-bone-fracture_executive.pdf
     March 01, 2012 - • Atrial fibrillation: Evidence is insufficient regarding the risk for this event. … Evidence is high for an increased risk for this event. … Evidence is high for an increased risk for this event. … Evidence is high for an increased risk for this event. … Evidence is insufficient regarding the risk for this event.